Effects of cigarette smoking on serum fluoride concentrations and renal function integrity after 1 MAC-h sevoflurane anaesthesia

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 8, 2006, Pages 982-987

  Laisalmi, M ^a,b,e   Kokki, H ^b,c   Soikkeli, A ^a   Markkanen, H ^a   Yli Hankala, A ^d   Rosenberg, P ^a   Lindgren, L ^d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e Department of Anaesthesiology and Intensive Care ^*  (Finland)

Author keywords

2 microglobulin; Drug metabolism; Renal function; Sevoflurane; Smoking; Tumour associated trypsin inhibitor (TATI)

Indexed keywords

APROTININ; BETA 2 MICROGLOBULIN; CREATININE; CYTOCHROME P450 2E1; DIAZEPAM; FLUORIDE; GLYCOPYRRONIUM BROMIDE; NITROUS OXIDE PLUS OXYGEN; PROPOFOL; ROCURONIUM; SEVOFLURANE; TOBACCO SMOKE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG METABOLISM; ELECTIVE SURGERY; FEMALE; GLOMERULUS; GYNECOLOGIC SURGERY; HEART RATE; HUMAN; INHALATION ANESTHESIA; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; LAPAROSCOPY; LAPAROTOMY; MINIMUM LUNG ALVEOLUS CONCENTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; FEMALE; FLUORIDES; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; METHYL ETHERS; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; TRYPSIN INHIBITOR, KAZAL PANCREATIC; URINATION;

EID: 33747651046     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01061.x     Document Type: Article

References (22)

1. Kharasch ED. Biotransformation of sevoflurane. Anesth Analg 1995; 81: S27-38.
2. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity: a study of dose-response in man. J Am Med Assoc 1973; 225: 1611-6.
3. Higuchi H, Sumikura H, Sumita S et al. Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 1995; 83: 449-58.
4. Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD. Clinical sevoflurane metabolism and disposition II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology 1995; 82: 1379-88.
5. Miller LG. Cigarettes and drug therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharm 1990; 9: 125-35.
6. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 52nd World Medical Association, General Assembly, Tokyo, Japan, 2004. URL http://www.wma.net/e/policy/b3.htm [accessed on 14 October 2005].
7. Committee for Proprietary Medicinal Products (CPMP). Note for Guidance on the Investigation of Bioavailability and Bioequivalence. EMEA, CPMP/EWP/QWP/1401/98, 2001. URL http://www.emea.eu.int/pdfs/human/ewp/140198en. pdf [accessed on 14 October 2005].
8. Tramonti G, Ferdeghini M, Donadio C et al. Tumor associated trypsin inhibitor (TATI) and renal function. Kidney Int Suppl 1997; 63: S179-S181.
9. Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G. Reappraisal of serum beta2-microglobulin as marker of GFR. Renal Fail 2001; 23: 419-29.
10. Wellwood JM, Ellis BG, Price RG, Hammond K, Thompson AE, Jones NF. Urinary N-acetyl-β-D-glucosaminidase activities in patients with renal disease. Br Med J 1975; 3: 408-11.
11. Fry BW, Taves DR. Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 1970; 75: 1020-5.
12. Laisalmi M, Soikkeli A, Kokki H et al. Fluoride metabolism in smokers and non-smokers following enflurane anaesthesia. Br J Anaesth 2003; 91: 800-4.
13. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalysing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane. Anesthesiology 1993; 79: 795-807.
14. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999; 36: 425-38.
15. Jusko WJ. Influence of cigarette smoking on drug metabolism in man. Drug Metab Rev 1979; 9: 221-36.
16. Wandel C, Neff S, Keppler G et al. The relationship between cytochrome P4502E1 activity and plasma fluoride levels after sevoflurane anesthesia. Anesth Analg 1997; 85: 924-30.
17. Lejus C, Fautrel A, Mallédant Y, Guillouzo A. Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes. Biochem Pharmacol 2002; 64: 1151-6.
18. Stenman UH. Tumour-associated trypsin inhibitor. Clin Chem 2002; 48: 1206-9.
19. Tsukamoto N, Hirabayashi Y, Shimizu R, Mitsuhata H. The effects of sevoflurane and isoflurane anesthesia on renal tubular function in patients with moderately impaired renal function. Anesth Analg 1996; 82: 909-13.
20. Higuchi H, Wada H, Usui Y, Goto K, Kanno M. Effects of probenecid on renal function in surgical patients anesthetized with low-flow sevoflurane. Anesthesiology 2001; 94: 21-31.
21. Renkin EM, Robinson RR. Glomerular filtration. N Engl J Med 1974; 290(14): 785-92.
22. Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002; 137: 744-52.